Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02122172
Title Afatinib in Advanced Refractory Urothelial Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Winship Cancer Institute Atlanta Georgia 30322 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Decatur Memorial Hospital Decatur Illinois 62526 United States Details
NorthShore University Health System Evanston Illinois 60201 United States Details
NYU Langone Health New York New York 10016 United States Details
University of North Carolina - Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field